Inhibrx Stock Price History
INBX Stock | USD 15.45 0.18 1.15% |
Below is the normalized historical share price chart for Inhibrx extending back to August 19, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Inhibrx stands at 15.45, as last reported on the 28th of November, with the highest price reaching 15.58 and the lowest price hitting 14.56 during the day.
If you're considering investing in Inhibrx Stock, it is important to understand the factors that can impact its price. At this stage we consider Inhibrx Stock to be not too volatile. Inhibrx holds Efficiency (Sharpe) Ratio of 0.0446, which attests that the entity had a 0.0446% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Inhibrx, which you can use to evaluate the volatility of the firm. Please check out Inhibrx's Risk Adjusted Performance of 0.0572, downside deviation of 2.86, and Market Risk Adjusted Performance of 4.74 to validate if the risk estimate we provide is consistent with the expected return of 0.14%.
At this time, Inhibrx's Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 323.3 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 38.2 M in 2024. . At this time, Inhibrx's Price To Sales Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 43.23 in 2024, whereas Price Earnings Ratio is likely to drop (7.79) in 2024. Inhibrx Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 19th of August 2020 | 200 Day MA 14.7374 | 50 Day MA 15.5254 | Beta 2.877 |
Inhibrx |
Sharpe Ratio = 0.0446
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | INBX | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
3.2 actual daily | 28 72% of assets are more volatile |
Expected Return
0.14 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Inhibrx is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Inhibrx by adding it to a well-diversified portfolio.
Price Book 1.2532 | Enterprise Value Ebitda 0.0169 | Price Sales 134.1187 | Shares Float 7.7 M | Wall Street Target Price 15 |
Inhibrx Stock Price History Chart
There are several ways to analyze Inhibrx Stock price data. The simplest method is using a basic Inhibrx candlestick price chart, which shows Inhibrx price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | September 19, 2024 | 17.49 |
Lowest Price | November 18, 2024 | 13.62 |
Inhibrx November 28, 2024 Stock Price Synopsis
Various analyses of Inhibrx's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Inhibrx Stock. It can be used to describe the percentage change in the price of Inhibrx from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Inhibrx Stock.Inhibrx Price Rate Of Daily Change | 0.99 | |
Inhibrx Price Action Indicator | 0.29 | |
Inhibrx Price Daily Balance Of Power | (0.18) |
Inhibrx November 28, 2024 Stock Price Analysis
Inhibrx Stock Price History Data
The price series of Inhibrx for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 has a statistical range of 3.87 with a coefficient of variation of 5.61. Under current investment horizon, the daily prices are spread out with arithmetic mean of 15.48. The median price for the last 90 days is 15.55.Open | High | Low | Close | Volume | ||
11/28/2024 | 14.71 | 15.58 | 14.56 | 15.45 | ||
11/27/2024 | 15.66 | 15.77 | 15.48 | 15.63 | 45,247 | |
11/26/2024 | 14.71 | 15.58 | 14.56 | 15.45 | 45,414 | |
11/25/2024 | 15.50 | 15.72 | 14.71 | 14.86 | 85,410 | |
11/22/2024 | 14.08 | 14.28 | 13.87 | 14.08 | 68,797 | |
11/21/2024 | 14.14 | 14.63 | 13.64 | 13.98 | 68,462 | |
11/20/2024 | 14.27 | 14.34 | 13.93 | 14.04 | 99,264 | |
11/19/2024 | 13.52 | 14.49 | 13.27 | 14.29 | 131,729 | |
11/18/2024 | 14.03 | 14.05 | 13.52 | 13.62 | 99,447 | |
11/15/2024 | 14.33 | 14.77 | 12.25 | 13.83 | 178,264 | |
11/14/2024 | 15.38 | 15.47 | 14.17 | 14.33 | 112,449 | |
11/13/2024 | 16.71 | 17.05 | 15.43 | 15.45 | 40,125 | |
11/12/2024 | 16.03 | 17.41 | 15.86 | 16.58 | 130,795 | |
11/11/2024 | 16.32 | 16.60 | 15.97 | 16.00 | 56,061 | |
11/08/2024 | 16.15 | 16.63 | 15.97 | 16.21 | 79,016 | |
11/07/2024 | 16.16 | 16.68 | 16.16 | 16.26 | 68,569 | |
11/06/2024 | 16.79 | 16.79 | 15.58 | 16.05 | 94,990 | |
11/05/2024 | 15.61 | 15.71 | 15.24 | 15.71 | 33,984 | |
11/04/2024 | 15.66 | 15.85 | 15.41 | 15.55 | 28,638 | |
11/01/2024 | 16.25 | 16.49 | 15.65 | 15.80 | 38,936 | |
10/31/2024 | 16.32 | 16.35 | 16.00 | 16.03 | 35,220 | |
10/30/2024 | 16.14 | 16.43 | 16.02 | 16.29 | 49,429 | |
10/29/2024 | 16.00 | 16.43 | 15.94 | 16.10 | 37,032 | |
10/28/2024 | 15.64 | 16.31 | 15.64 | 16.00 | 46,620 | |
10/25/2024 | 15.57 | 15.79 | 15.34 | 15.37 | 26,632 | |
10/24/2024 | 15.71 | 15.89 | 15.30 | 15.37 | 21,316 | |
10/23/2024 | 15.66 | 15.87 | 15.32 | 15.76 | 33,577 | |
10/22/2024 | 15.50 | 16.00 | 15.31 | 15.80 | 28,290 | |
10/21/2024 | 15.84 | 15.93 | 15.50 | 15.50 | 20,253 | |
10/18/2024 | 16.21 | 16.25 | 15.82 | 16.00 | 38,327 | |
10/17/2024 | 16.12 | 17.02 | 15.85 | 16.17 | 83,152 | |
10/16/2024 | 16.02 | 16.13 | 15.63 | 16.05 | 91,407 | |
10/15/2024 | 15.55 | 16.20 | 15.46 | 15.74 | 71,108 | |
10/14/2024 | 15.66 | 15.80 | 15.49 | 15.50 | 51,327 | |
10/11/2024 | 15.50 | 15.64 | 15.31 | 15.64 | 83,718 | |
10/10/2024 | 15.66 | 15.77 | 15.37 | 15.58 | 83,925 | |
10/09/2024 | 16.00 | 16.20 | 15.45 | 15.67 | 106,679 | |
10/08/2024 | 15.56 | 16.35 | 15.50 | 15.99 | 176,627 | |
10/07/2024 | 14.77 | 15.48 | 14.71 | 15.27 | 66,592 | |
10/04/2024 | 15.06 | 15.06 | 14.71 | 14.76 | 53,148 | |
10/03/2024 | 15.28 | 15.29 | 14.80 | 14.88 | 87,045 | |
10/02/2024 | 15.45 | 15.91 | 15.36 | 15.40 | 94,780 | |
10/01/2024 | 15.56 | 15.66 | 15.11 | 15.45 | 175,396 | |
09/30/2024 | 15.55 | 16.01 | 15.42 | 15.66 | 105,381 | |
09/27/2024 | 15.33 | 16.09 | 15.16 | 15.52 | 55,395 | |
09/26/2024 | 15.57 | 15.89 | 15.31 | 15.33 | 83,863 | |
09/25/2024 | 15.59 | 15.59 | 15.15 | 15.42 | 135,451 | |
09/24/2024 | 15.63 | 15.90 | 15.42 | 15.50 | 104,163 | |
09/23/2024 | 16.34 | 16.50 | 15.62 | 15.67 | 119,772 | |
09/20/2024 | 17.39 | 17.39 | 16.23 | 16.28 | 302,024 | |
09/19/2024 | 17.22 | 17.60 | 16.77 | 17.49 | 56,246 | |
09/18/2024 | 17.13 | 17.48 | 16.99 | 16.99 | 72,151 | |
09/17/2024 | 17.66 | 17.79 | 17.09 | 17.22 | 83,776 | |
09/16/2024 | 16.43 | 17.74 | 16.35 | 17.43 | 186,889 | |
09/13/2024 | 15.36 | 16.57 | 15.25 | 16.41 | 166,989 | |
09/12/2024 | 14.96 | 15.35 | 14.51 | 15.08 | 173,744 | |
09/11/2024 | 15.50 | 15.63 | 14.98 | 15.00 | 110,339 | |
09/10/2024 | 15.18 | 15.29 | 15.00 | 15.18 | 72,666 | |
09/09/2024 | 15.24 | 15.73 | 15.01 | 15.20 | 126,369 | |
09/06/2024 | 16.09 | 16.34 | 15.05 | 15.06 | 119,281 | |
09/05/2024 | 15.98 | 16.09 | 15.67 | 16.04 | 78,045 |
About Inhibrx Stock history
Inhibrx investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Inhibrx is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Inhibrx will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Inhibrx stock prices may prove useful in developing a viable investing in Inhibrx
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 47.1 M | 38.2 M | |
Net Loss | -130.7 M | -124.2 M |
Inhibrx Stock Technical Analysis
Inhibrx technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Diagnostics Now
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings |
All Next | Launch Module |
Inhibrx Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Inhibrx's price direction in advance. Along with the technical and fundamental analysis of Inhibrx Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Inhibrx to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0572 | |||
Jensen Alpha | 0.1925 | |||
Total Risk Alpha | (0.29) | |||
Sortino Ratio | 0.0286 | |||
Treynor Ratio | 4.73 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Inhibrx Stock Analysis
When running Inhibrx's price analysis, check to measure Inhibrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx is operating at the current time. Most of Inhibrx's value examination focuses on studying past and present price action to predict the probability of Inhibrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibrx's price. Additionally, you may evaluate how the addition of Inhibrx to your portfolios can decrease your overall portfolio volatility.